QIAstat-Dx Meningitis/Encephalitis (ME) Panel
FDA 510(k) clearance K242256 · decided 2024-10-29
Clearance details
- K-number
- K242256
- Device name
- QIAstat-Dx Meningitis/Encephalitis (ME) Panel
- Applicant
- QIAGEN GmbH
- Decision
- Substantially Equivalent
- Date received
- 2024-07-31
- Decision date
- 2024-10-29
- Days to decision
- 90 days
- Clearance type
- Traditional
- Product code
- PLO
- Device class
- 2
- Regulation number
- 866.3970
- Medical specialty
- Microbiology
- Advisory committee
- Microbiology
- Location
- Hilden, DE
- Third-party review
- No
- Expedited review
- No
+ Add to Predicate Builder ◉ Watch QIAGEN GmbH
Need this as data, not a web page?
Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.
Similar devices under this product code
Devices cleared under the same product code - the starting set for predicate research.
| Record | Firm | Date |
|---|---|---|
| Simplexa VZV Direct, Simplexa VZV Positive Control Pack (K190219) | Diasorin Molecular, LLC | 2019-05-13 |
| FilmArray Meningitis/Encephalitis (ME) Panel for use with FilmArray Torch (K160462) | Biofire Diagnostics, LLC | 2016-03-17 |
| FilmArray Meningitis/Encephalitis(ME) Panel (DEN150013) | Biofire Diagnostics, LLC | 2015-10-08 |
Recalls involving this device
No recalls on record reference this clearance.
PMA approvals by this applicant
| Record | Firm | Date |
|---|---|---|
| therascreen® PIK3CA RGQ PCR Kit (P190001/S002) | QIAGEN GmbH | 2025-10-22 |
| QIAGEN therascreen® FGFR RGQ RT-PCR Kit (P180043/S007) | QIAGEN GmbH | 2025-10-03 |
| therascreen® KRAS RGQ PCR Kit (P110027/S018) | QIAGEN GmbH | 2025-01-16 |
| therascreen FGFR RGQ PCR Kit (P180043/S008) | QIAGEN GmbH | 2024-12-06 |
| therascreen FGFR RGQ RT-PCR Kit (P180043/S009) | QIAGEN GmbH | 2024-10-23 |
| therascreen® KRAS RGQ PCR Kit (P110027/S017) | QIAGEN GmbH | 2024-06-21 |
| therascreen FGFR RGQ RT-PCR Kit (P180043/S006) | QIAGEN GmbH | 2023-12-22 |
| QIAGEN therascreen® KRAS RGQ PCR Kit (P110027/S016) | QIAGEN GmbH | 2023-10-06 |